Company news

Currenc Group Inc. news in 2022

Currenc Group Inc.'s news releases, calls and decks from 2022, newest first.

View company

CURE Pharmaceutical Letter to Shareholders

December 14, 2022

CURE Pharmaceutical Reports Third Quarter 2022 Results With Strong Sequential and Year Over Year Revenue Increases and Continued High Margins

November 21, 2022

Avenir Wellness Solutions to Present at Investor Summit Group's Q4 Conference

November 9, 2022

Cure Pharmaceutical Holding to Present at the LD Micro Main Event XV

October 23, 2022

Cure Pharmaceutical Reports Second Quarter 2022 Results With Increased Sequential Revenues and Strong Margins

September 1, 2022

CURE Pharmaceutical Announces Rob Davidson as new Chairman of the Board and Appointment of Rob Costantino as Member of the Board and Audit Committee Chairman

August 15, 2022

CURE Pharmaceutical Provided Full Corporate Update on Recent Shareholder Call

August 8, 2022

CURE Pharmaceutical Announces the Appointment of New Board Member

August 1, 2022

CURE Pharmaceutical Announces Teleconference With Investors

July 31, 2022

CURE Pharmaceutical Announces the Sale of a Portion of its Platform Technology IP for $20 Million

July 27, 2022

CURE Pharmaceutical Announces Positive Findings from Study at Cincinnati Children’s Hospital Medical Center (CCHMC) Using CURE’s Proprietary, Oral Thin Film (OTF) High, Single Dose Vitamin D in Pediatric Patients Pre- and Post-Hematopoietic Stem Cell...

May 11, 2022

Sera Labs Inc. Products Now Available at Walmart, Bed Bath & Beyond, CVS and Target.com

April 13, 2022

CURE Pharmaceutical and Milagro Pharmaceuticals Collaborate for Registration and Approval to Sell Sildenafil Oral Thin Film in Mexico

March 2, 2022